SLI
2.019,59
PKT
+11,20
PKT
+0,56
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
08.08.17 | Givaudan overweight | JP Morgan Chase & Co. | |
08.08.17 | Holcim Neutral | JP Morgan Chase & Co. | |
08.08.17 | Holcim buy | Citigroup Corp. | |
08.08.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
08.08.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
07.08.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
07.08.17 | UBS neutral | RBC Capital Markets | |
07.08.17 | Swiss Re buy | Goldman Sachs Group Inc. | |
07.08.17 | Swiss Re kaufen | DZ BANK | |
07.08.17 | Swiss Re Sell | UBS AG | |
07.08.17 | Swiss Re buy | Deutsche Bank AG | |
04.08.17 | Novartis buy | Baader Bank | |
04.08.17 | Swiss Re Sell | UBS AG | |
04.08.17 | Swiss Re Hold | S&P Capital IQ | |
04.08.17 | Swiss Re Reduce | Commerzbank AG | |
04.08.17 | Swiss Re Hold | Baader Bank | |
04.08.17 | Swiss Re Outperform | RBC Capital Markets | |
04.08.17 | Swiss Re market-perform | Bernstein Research | |
03.08.17 | Nestlé buy | Citigroup Corp. | |
03.08.17 | Holcim Hold | Deutsche Bank AG | |
03.08.17 | UBS buy | Deutsche Bank AG | |
01.08.17 | UBS buy | Citigroup Corp. | |
01.08.17 | UBS overweight | JP Morgan Chase & Co. | |
01.08.17 | UBS overweight | JP Morgan Chase & Co. | |
01.08.17 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
31.07.17 | Roche overweight | JP Morgan Chase & Co. | |
31.07.17 | UBS Neutral | Credit Suisse Group | |
31.07.17 | UBS overweight | JP Morgan Chase & Co. | |
31.07.17 | UBS buy | Goldman Sachs Group Inc. | |
31.07.17 | UBS Neutral | Goldman Sachs Group Inc. | |
28.07.17 | Holcim Hold | Deutsche Bank AG | |
28.07.17 | Nestlé overweight | JP Morgan Chase & Co. | |
28.07.17 | UBS Hold | S&P Capital IQ | |
28.07.17 | Roche overweight | JP Morgan Chase & Co. | |
28.07.17 | Roche Hold | Deutsche Bank AG | |
28.07.17 | UBS buy | Citigroup Corp. | |
28.07.17 | UBS buy | UBS AG | |
28.07.17 | Nestlé buy | Kepler Cheuvreux | |
28.07.17 | Nestlé buy | Goldman Sachs Group Inc. | |
28.07.17 | UBS buy | Deutsche Bank AG |